GnRH antagonist (GnRHant) does not have a negative effect on endometrial receptivity: a comparison of outcomes of high quality euploid blastocysts in fresh antagonist vs. agonist cycles

      GnRH antagonists have been postulated to adversely impact implantation via a direct effect on endometrial receptivity. Evaluation has been difficult because of the complexity of controlling for embryo quality. This study employs a model which rigorously controls for embryo quality to determine if endometrial receptivity is impacted by the use of GnRHant versus GnRH agonist (GnRHa).
      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect